Literature DB >> 2206556

Cloning by polymerase chain reaction of a new mouse TGF-beta, mTGF-beta 3.

F Denhez1, R Lafyatis, P Kondaiah, A B Roberts, M B Sporn.   

Abstract

Two TGF-beta s, TGF-beta 1 and 2, have previously been isolated from the mouse. Here we report the isolation of a murine TGF-beta 3 cDNA. RNAs extracted from 15-day-old mouse embryos and several mouse cell lines were reverse-transcribed. These cDNA mixtures were used as substrates for polymerase chain-reaction amplifications, using oligonucleotides designed on the basis of known human and chicken TGF-beta 3 sequences, including the initiation and stop codons. Several overlapping cDNAs containing either the amino-terminal domain or the carboxy-terminal domain, as well as the complete 1.2-kb coding region of the mouse TGF-beta 3 cDNA were obtained. The mouse TGF-beta 3 coding region is 1230 nucleotides long and codes for a 410 amino acid polypeptide very similar to its human counterpart. This cDNA hybridizes to a unique 3.5-kb RNA and is differentially expressed in various mouse tissues and at different embryonic stages.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206556     DOI: 10.3109/08977199009108276

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  11 in total

1.  Sequence specific protein binding to and activation of the TGF-beta 3 promoter through a repeated TCCC motif.

Authors:  R Lafyatis; F Denhez; T Williams; M Sporn; A Roberts
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

2.  Distinct modulatory actions of TGF-beta and LIF on neurotrophin-mediated survival of developing sensory neurons.

Authors:  K Krieglstein; K Unsicker
Journal:  Neurochem Res       Date:  1996-07       Impact factor: 3.996

3.  Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis.

Authors:  R Lafyatis; R Lechleider; A B Roberts; M B Sporn
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

4.  Identification of a novel transforming growth factor-beta (TGF-beta6) gene in fish: regulation in skeletal muscle by nutritional state.

Authors:  Bruria Funkenstein; Elena Olekh; Sonia B Jakowlew
Journal:  BMC Mol Biol       Date:  2010-05-12       Impact factor: 2.946

5.  Association of MSX1 and TGFB3 with nonsyndromic clefting in humans.

Authors:  A C Lidral; P A Romitti; A M Basart; T Doetschman; N J Leysens; S Daack-Hirsch; E V Semina; L R Johnson; J Machida; A Burds; T J Parnell; J L Rubenstein; J C Murray
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

6.  Terminal differentiation of Sol 8 myoblasts is retarded by a transforming growth factor-beta autocrine regulatory loop.

Authors:  Séverine Allegra; Jacques Yuan Li; José Maria Saez; Dominique Langlois
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

7.  Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.

Authors:  S Nikol; J M Isner; J G Pickering; M Kearney; G Leclerc; L Weir
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells.

Authors:  B A Arrick; R L Grendell; L A Griffin
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  Overexpression of transforming growth factor-beta in transgenic mice carrying the human T-cell lymphotropic virus type I tax gene.

Authors:  S J Kim; T S Winokur; H D Lee; D Danielpour; K Y Kim; A G Geiser; L S Chen; M B Sporn; A B Roberts; G Jay
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.

Authors:  S M Wahl; J B Allen; N McCartney-Francis; M C Morganti-Kossmann; T Kossmann; L Ellingsworth; U E Mai; S E Mergenhagen; J M Orenstein
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.